ARTICLE | Clinical News
AlphaRx, Gaia BioPharma preclinical data
July 13, 2009 7:00 AM UTC
In 3 different rat models of acute liver injury, GAI-122 significantly reduced alanine aminotransferase (ALT) levels vs. controls. Gaia has an exclusive license to GAI-122 from AlphaRx. GAI-122 is a c...